Posts Tagged ‘Mithoefer’
Tuesday, November 27th, 2012
Whether a person is traumatized by sexual abuse, crime, war or the workplace, their resulting posttraumatic stress disorder (PTSD) can be resistant to traditional psychotherapy. A breakthrough alternative may be on the horizon — methylenedioxymethamphetamine (MDMA) in pure form combined with psychotherapy. According to the Multidisciplinary Association for Psychedelic Studies, which funded the research, MDMA is not the same as Ecstasy. Substances sold on the street under the name Ecstasy do often contain MDMA, but frequently also contain ketamine, caffeine, BZP, and other narcotics and stimulants.
A randomized, double-blind and placebo-controlled study of twenty-one individuals with treatment-resistant PTSD was conducted by Michael Mithoefer, M.D. with co-therapist Ann Mithoefer, B.S.N. in Charleston, SC. The early phase was completed in 2008 with results published in the Journal of Psychopharmacology in 2010.
Over three years later, the long-term follow up was completed by the research-clinicians. The positive benefits from the MDMA + psychotherapy protocol lasted for 17 of 20 individuals available for the study. They reported minor to no symptoms. New life stressors caused relapse for the others. The follow-up study also appeared in the Journal of Psychopharmacology on Nov. 10, 2012.
Tags: Doblin, Ecstasy, MAPS, MDMA, Mithoefer, PTSD treatment
Posted in Bullying & Health, Bullying-Related Research, Social/Mgmt/Epid Sciences, WBI Education | No Archived Comments | Post A Comment (